17 / September / 2024 New uses for existing drugs International programs weigh up costs and benefits in the search for new forms of treatment with existing drugs By Editorial staff
02 / September / 2024 Telemedicine guidelines reduce unnecessary prescriptions Study shows that the adoption of specific care guidelines reduced the prescription of antibiotics and antimicrobials for COVID-19 patients By Editorial staff
23 / August / 2024 AI increases colonoscopy rates in the US New York study used digital technology to identify cancer patients who missed colonoscopy exams By Editorial staff
21 / August / 2024 The atlas that could revolutionize medicine An international consortium, supported by Brazilian researchers, reveals details of the human body’s molecular composition and operations at a cellular level By Gilberto Stam
19 / August / 2024 How climate change impacts the health of Latin Americans A report published in The Lancet by Latin American scientists warns that worsening diseases and economic losses could significantly affect poorer populations By Letícia Naísa
14 / August / 2024 The urgent need for green medicine Pharmaceutical pollution of ecosystems is a threat to biodiversity, ecosystem services, and public health By Editorial staff
09 / August / 2024 Bioethics and AI: what role do clinicians and patients play? Researchers identify problems with the use of programs such as ChatGPT in the clinician-patient relationship and suggest how to make better use of AI tools By Editorial staff
24 / July / 2024 Extreme heat at the Paris Olympics Researchers and athletes come together to warn of the health risks of high temperatures during the games, and propose a review of sponsorship by the fossil fuel sector By Editorial staff
05 / July / 2024 Time-saving tool checks for conflicts of interest on exam boards Conflitulus Lattes cross-checks information from the résumés of dozens of candidates and examiners, and may save the organizers hours of work By Gilberto Stam
12 / June / 2024 COVID-19: High levels of immunity hinder clinical trials Clinical trials conducted in 2021 and 2022 were unable to find a dosage of the SARS-CoV-2 virus capable of infecting volunteers in challenge studies By Editorial staff
